Pharmacare: The Unfinished Business of Canadian Medicare
Abstract
Canada has the unique distinction of being the only country with a universal national healthcare care plan not to include Pharmacare: the universal, public coverage of prescription drugs. A literature review was conducted to investigate the benefits of implementing Pharmacare. Historically, little progress has been made toward a universal drug plan. Pharmacare would ensure that all Canadians receive equitable access to safe, cost-effective, and appropriately prescribed medicines. Additionally, universal, publicly managed drug coverage ensures that prescriptions are contingent on contemporary medical evidence by integrating the management of medical and hospital care. Finally, Pharmacare would save billions of dollars, hence stimulating the federal and provincial economies and aiding Canadian businesses. Pharmacare is the only suitable option as the current fragmented patchwork of public and private drug plans become increasingly unsustainable.
Downloads
Published
How to Cite
Issue
Section
License
LicenseAuthors contributing to Revue YOUR Review agree to release their articles under one of three Creative Commons licenses: Creative Commons Attribution 4.0 International; Creative Commons Attribution-NonCommercial 4.0 International; or Creative Commons Attribution-NoDerivatives 4.0 International. All editorial content, posters, and abstracts on this site are licensed under Creative Commons Attribution-NoDerivatives 4.0 International. For further information about each license, see:
https://creativecommons.org/licenses/
In all cases, authors retain copyright of their work and grant the e-journal right of first publication. Authors are able to enter into other contractual arrangements for the non-exclusive distribution of the e-journal's published version of the article (e.g., post it to an institutional repository or publish it in a book or in another journal), with an acknowledgement of its initial publication in this e-journal.